Physician profile
David J Bailey
NPI 1720023864
$5,382.14
in general payments reported to CMS, 2019-2025
18 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $353 · 2021: $854 · 2022: $1,464 · 2023: $1,217 · 2024: $664 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,638 · Travel and Lodging: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.64 |
| Travel and Lodging | $476.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,152.15 | 2019-2024 | Impella |
| Boston Scientific Corporation | $1,223.73 | 2019-2025 | Crossboss, Watchman Flx, Opticross |
| Janssen Pharmaceuticals, INC | $393.97 | 2019-2022 | |
| Cvrx, INC. | $304.41 | 2022-2025 | Barostim Neo System |
| Intuitive Surgical, INC. | $209.24 | 2019 | |
| Abbott Laboratories | $194.24 | 2020-2023 | Optis, Dragonfly Opstar |
| Pfizer INC. | $148.06 | 2022-2024 | |
| Silk Road Medical, INC. | $139.91 | 2021 | |
| Teleflex LLC | $115.62 | 2022 | |
| Amgen INC. | $110.47 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $104.20 | 2019-2023 | |
| Heartflow, INC. | $92.55 | 2024-2025 | |
| Philips North America LLC | $67.79 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $42.88 | 2024-2025 | Camzyos |
| Terumo Medical Corporation | $26.49 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $23.13 | 2019 | |
| Tactile Systems Technology INC | $16.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.32 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.